EP 1087790 A2 20010404 - USE OF A COMPOUND HAVING AFFINITY FOR THE BENZODIAZEPINE MITOCHONDRIAL RECEPTOR IN CANCER THERAPY
Title (en)
USE OF A COMPOUND HAVING AFFINITY FOR THE BENZODIAZEPINE MITOCHONDRIAL RECEPTOR IN CANCER THERAPY
Title (de)
VERWENDUNG EINER VERBINDUNG MIT HOHER AFFINITÄT FÜR DEN MITOCHONDRIALEN BENZODIAZEPINE REZEPTOR IN EINEM ARZNEIMITTEL ZUR KREBS-THERAPIE
Title (fr)
UTILISATION D'UN COMPOSE POSSEDANT UNE AFFINITE POUR LE RECEPTEUR MITOCHONDRIAL DES BENZODIAZEPINES DANS UN MEDICAMENT POUR LA THERAPIE DU CANCER
Publication
Application
Priority
- FR 9901383 W 19990611
- FR 9807864 A 19980622
Abstract (en)
[origin: FR2779963A1] A Composition for treating cancer comprises a compound (A) with affinity for mitochondrial benzodiazepine receptors and an agent to induce apoptosis, for simultaneous, separate, or sustained use.
IPC 1-7
IPC 8 full level
A61K 31/47 (2006.01); A61K 45/06 (2006.01)
CPC (source: EP US)
A61K 31/47 (2013.01 - EP US); A61K 45/06 (2013.01 - EP US)
Citation (search report)
See references of WO 9966958A2
Designated contracting state (EPC)
DE FR GB IT
DOCDB simple family (publication)
FR 2779963 A1 19991224; AU 3508999 A 20000106; CA 2274741 A1 19991222; EP 1087790 A2 20010404; US 6319931 B1 20011120; WO 9966958 A2 19991229; WO 9966958 A3 20000420
DOCDB simple family (application)
FR 9807864 A 19980622; AU 3508999 A 19990616; CA 2274741 A 19990614; EP 99923718 A 19990611; FR 9901383 W 19990611; US 33215299 A 19990614